AI Summary
We reviewed 279 live results for skyrizi complete and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Immunology and Patient Support.
Comparison Table
Recommended
Skyrizi Complete
Source: AbbVie Inc.
Description
Skyrizi Complete is a comprehensive patient support program designed to help patients navigate their treatment journey. The program offers financial assistance, including a $0 copay card for eligible commercially insured patients, and personalized support through one-on-one Nurse Ambassadors. It also provides logistical resources such as a sharps disposal mail-back program, the Skyrizi Complete App for dose tracking, and insurance coverage support to facilitate access to the medication.
Best for
financial assistance seekers, patient support services, new injection training, copay savings for biologics and personalized nurse guidance
View Details
Rating
Skyrizi (risankizumab-rzaa)
Source: AbbVie Inc.
Description
Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body.
Best for
moderate-to-severe plaque psoriasis, active psoriatic arthritis, Crohn's disease management, ulcerative colitis treatment and biologic therapy seekers
View Details
Rating
Skyrizi (risankizumab)
Source: AbbVie Pharmaceuticals (Thailand) Ltd.
Description
Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading.
Best for
plaque psoriasis patients, psoriatic arthritis management, Crohn's disease treatment and long-term biologic therapy
View Details
Rating
| Compare | Skyrizi Complete | Skyrizi (risankizumab-rzaa) | Skyrizi (risankizumab) |
|---|---|---|---|
| Source | AbbVie Inc. | AbbVie Inc. | AbbVie Pharmaceuticals (Thailand) Ltd. |
| Description | Skyrizi Complete is a comprehensive patient support program designed to help patients navigate their treatment journey. The program offers financial assistance, including a $0 copay card for eligible commercially insured patients, and personalized support through one-on-one Nurse Ambassadors. It also provides logistical resources such as a sharps disposal mail-back program, the Skyrizi Complete App for dose tracking, and insurance coverage support to facilitate access to the medication. | Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body. | Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading. |
| Best for | financial assistance seekers, patient support services, new injection training, copay savings for biologics and personalized nurse guidance | moderate-to-severe plaque psoriasis, active psoriatic arthritis, Crohn's disease management, ulcerative colitis treatment and biologic therapy seekers | plaque psoriasis patients, psoriatic arthritis management, Crohn's disease treatment and long-term biologic therapy |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Skyrizi Complete from AbbVie Inc.."
I picked this because This support program provides essential financial and educational resources to help manage the high cost and administration requirements of specialty biologic therapy.
Share this search
Related Finds